Key result
Review summarizes the current safety and efficacy of DOAC antidotes in Japan.
Answers are grounded in this paper and cite their sources.
Supports DOAC antidote use in Japanese bleeding cases; leaves open need for prospective trials to confirm efficacy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eitaro Kodani (2026) studied this question. Antidotes for direct oral anticoagulants have been reviewed regarding their current safety and efficacy status in Japan.
Synapse has enriched 10 related papers. Consider them for comparative context: